Risk assessment/mitigation is a key unmet need
DeltaTrak (Pleasonton, CA), manufacturers and service providers of environmental monitoring solutions, and Modality Solutions (Indianapolis), an engineering-consulting firm, have expanded a partnership whereby Modality can provide value-added services for cold-chain management processes at manufacturers and logistics providers. Specific services include gap analysis for GDP/GMP compliance, cargo security audits, risk and environmental assessments, among others.
Peter Norton, director of business development at DeltaTrak, notes that Modality is not a reseller for his company, but does serve to raise the awareness level of organizations involved in temperature-controlled distribution in ways that could be beneficial to DeltaTrak. “A key area is the requirements in new GDP regulations for performing risk assessments and risk mitigation,” he says. “To be fully compliant, companies need to look beyond their day-to-day processes.”
“Partnering with DeltaTrak allows us to offer cost-effective monitoring solutions and FlashTrak Telematics technology to help improve cold chain management from manufacturing to distribution,” said Modality president, Gary Hutchinson, in a statement.
DeltaTrak offers reusable and single-use dataloggers, temperature indicators, and software and online systems for shipment tracking. Most recently, a vaccine datalogger equipped with a glycol-encased temperature probe (in order to stabilize temperature readings) has been prequalified for use by the World Health Organisation.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.